Immunic Total Assets from 2010 to 2024

IMUX Stock

USD 1.10 0.01 0.90%

Immunic Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2012-12-31

Previous Quarter

86.5 M

Current Value

64.8 M

Quarterly Volatility

40.6 M

Yuan Drop

Covid

Check Immunic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immunic's main balance sheet or income statement drivers, such as Depreciation And Amortization of 105.5 K, Interest Expense of 730.2 K or Other Operating Expenses of 54.8 M, as well as many indicators such as Price To Sales Ratio of 17.3 K, Dividend Yield of 0.0064 or PTB Ratio of 1.46. Immunic financial statements analysis is a perfect complement when working with Immunic Valuation or Volatility modules.

Check out the analysis of Immunic Correlation against competitors.

For more information on how to buy Immunic Stock please use our How to Invest in Immunic guide.

Latest Immunic's Total Assets Growth Pattern

Below is the plot of the Total Assets of Immunic over the last few years. Total assets refers to the total amount of Immunic assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Immunic books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Immunic's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immunic's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 54.3 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Immunic Total Assets Regression Statistics

	Arithmetic Mean	69,577,882
	Geometric Mean	41,405,941
	Coefficient Of Variation	72.18
	Mean Deviation	39,423,458
	Median	64,026,000
	Standard Deviation	50,222,242
	Sample Variance	2522.3T
	Range	165.9M
	R-Value	0.59
	Mean Square Error	1765.8T
	R-Squared	0.35
	Significance	0.02
	Slope	6,643,145
	Total Sum of Squares	35311.8T

Immunic Total Assets History

	2024	81.3 M
	2023	54.3 M
	2022	127.8 M
	2021	139.1 M
	2020	167.9 M
	2019	66 M
	2018	15 M

Other Fundumenentals of Immunic

Intangibles To Total Assets

Immunic Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Short Term Debt	Short Term Investments	Common Stock	Net Tangible Assets	Capital Surpluse	Property Plant Equipment	Net Receivables	Intangible Assets	Net Invested Capital	Net Working Capital	Capital Stock	Current Deferred Revenue
Total Assets		0.96	-0.95	-0.04	0.57	-0.53	0.97	-0.23	-0.48	0.28	0.34	0.15	-0.41	0.72	0.44	0.78	0.74	-0.41	0.28
Total Stockholder Equity	0.96		-0.94	-0.04	0.55	-0.73	0.93	-0.14	-0.6	0.32	0.18	0.13	-0.38	0.59	0.42	0.71	0.66	-0.4	0.15
Net Debt	-0.95	-0.94		0.03	-0.68	0.56	-0.98	0.34	0.49	-0.36	-0.36	-0.24	0.25	-0.61	-0.28	-0.68	-0.7	0.2	-0.17
Retained Earnings	-0.04	-0.04	0.03		0.13	0.19	-0.09	-0.15	0.3	-0.84	0.12	-0.79	0.52	-0.22	-0.47	0.19	0.13	-0.27	-0.64
Accounts Payable	0.57	0.55	-0.68	0.13		-0.33	0.65	-0.33	-0.41	0.24	0.3	0.14	0.07	0.19	-0.01	0.12	0.15	0.07	0.19
Total Liab	-0.53	-0.73	0.56	0.19	-0.33		-0.52	-0.16	0.79	-0.38	0.36	-0.06	0.25	-0.07	-0.27	-0.17	-0.1	0.25	0.07
Total Current Assets	0.97	0.93	-0.98	-0.09	0.65	-0.52		-0.35	-0.45	0.38	0.4	0.28	-0.32	0.71	0.34	0.7	0.73	-0.21	0.3
Short Term Debt	-0.23	-0.14	0.34	-0.15	-0.33	-0.16	-0.35		-0.17	0.06	-0.68	-0.18	-0.55	-0.19	0.57	-0.25	-0.42	-0.47	-0.02
Short Term Investments	-0.48	-0.6	0.49	0.3	-0.41	0.79	-0.45	-0.17		-0.45	0.3	-0.12	0.34	0.06	-0.32	0.0	0.12	0.27	-0.11
Common Stock	0.28	0.32	-0.36	-0.84	0.24	-0.38	0.38	0.06	-0.45		-0.08	0.87	-0.45	0.25	0.45	-0.07	0.01	0.34	0.55
Net Tangible Assets	0.34	0.18	-0.36	0.12	0.3	0.36	0.4	-0.68	0.3	-0.08		0.32	0.07	0.5	0.01	0.45	0.57	0.25	0.32
Capital Surpluse	0.15	0.13	-0.24	-0.79	0.14	-0.06	0.28	-0.18	-0.12	0.87	0.32		-0.34	0.36	0.38	-0.03	0.12	0.59	0.67
Property Plant Equipment	-0.41	-0.38	0.25	0.52	0.07	0.25	-0.32	-0.55	0.34	-0.45	0.07	-0.34		-0.49	-0.93	-0.29	-0.18	0.5	-0.54
Net Receivables	0.72	0.59	-0.61	-0.22	0.19	-0.07	0.71	-0.19	0.06	0.25	0.5	0.36	-0.49		0.53	0.76	0.8	-0.19	0.6
Intangible Assets	0.44	0.42	-0.28	-0.47	-0.01	-0.27	0.34	0.57	-0.32	0.45	0.01	0.38	-0.93	0.53		0.35	0.22	-0.44	0.55
Net Invested Capital	0.78	0.71	-0.68	0.19	0.12	-0.17	0.7	-0.25	0.0	-0.07	0.45	-0.03	-0.29	0.76	0.35		0.96	-0.47	0.05
Net Working Capital	0.74	0.66	-0.7	0.13	0.15	-0.1	0.73	-0.42	0.12	0.01	0.57	0.12	-0.18	0.8	0.22	0.96		-0.22	0.08
Capital Stock	-0.41	-0.4	0.2	-0.27	0.07	0.25	-0.21	-0.47	0.27	0.34	0.25	0.59	0.5	-0.19	-0.44	-0.47	-0.22		0.15
Current Deferred Revenue	0.28	0.15	-0.17	-0.64	0.19	0.07	0.3	-0.02	-0.11	0.55	0.32	0.67	-0.54	0.6	0.55	0.05	0.08	0.15

Click cells to compare fundamentals

About Immunic Financial Statements

Immunic investors use historical fundamental indicators, such as Immunic's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immunic. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	54.3 M	81.3 M
Intangibles To Total Assets	0.21	0.20

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Immunic Stock Analysis

When running Immunic's price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC